This site did not show evidence of storing passwords in plaintext.
This site does allow secured connections (https)
This site did show a clear way to unsubscribe from their emails
This site does verify your email address.
Membership Emails
Below is a sample of the emails you can expect to receive when signed up to Cyber Civil Rights Initiative.
If you are unable to see the message below, click here to view.
www.ascp.org
JULY 2020
New Books from ASCP Press
Member Price: $14929
Non-Member Price: $18629
Member Price: $23929
Non-Member Price: $29929
Member Price: $19929
Non-Member Price: $24929
Visit the online catalog for these and other titles and to order.
Shop Now
ASCP VIRTUAL TOWN HALLS
The new ASCP Town Hall series addresses the main concerns affecting the laboratory team during the COVID-19 crisis and beyond. As information changes rapidly regarding COVID-19, ASCP is working to ensure you have the most up-to-date information. These Town Halls are eligible for 1 CME/CMLE credit.
+ Read More
Update Contact Info
When was the last time you reviewed your ASCP Profile? The information you share informs program development, member benefits and more to ensure ASCP is supporting you with the tools you need to be successful in the lab! Update your contact information, employment information and communication preferences with ASCP today.
+ Read More
Featured Education
Expand your knowledge and provide better patient outcomes with ASCP's innovative education resources, including state-of-the-art multidisciplinary education for free!
Learn More
Immunology Education
Questions regarding Immuno-oncology (IO)? ASCP has a number of new online modules focused on IO including the new ASCP Tumor Board Simulation: Immune-Related Adverse Events. This interactive tumor board simulation on immune-related adverse events (irAEs) is designed to help you gain deeper scientific knowledge and skills in diagnosing, testing, early detection, and optimal management of irAEs. Learn More
Funded by an independent educational grant from Bristol-Myers Squibb.
HER2-positive and HER2-low Breast Cancer
Pathologists, laboratory professionals, and other members of the cancer care team need to ensure that they are applying the latest clinical practice recommendations to ensure optimal HER2 testing processes. Advances in the science of HER2-low breast cancer may lead to new diagnostic and treatment paradigms. Learn More
Supported by an independent educational grant from Daiichi Sankyo, Inc.
Castration-Resistant Prostate Cancer
Diagnosis and Testing Considerations with the Emerging Use of PARP Inhibitors addresses specified gaps in the understanding of PARP inhibitors and their implications for the selection and treatment of patients with castration-resistant prostate cancer (CRPC). Learn More
Supported by an independent educational grant from Pfizer, Inc.
Donate Now
ABOUT THIS MESSAGE | You are receiving this e-mail because you have been certified by the Board of Certification (BOC), are a member of ASCP, have attended ASCP programs/meetings or made a purchase from ASCP. If you no longer wish to receive e-mails of this kind from ASCP, please login to change your email preferences or call Customer Service at 800.267.2727. This e-mail message complies with all CAN-SPAM 2004 regulations. It was sent to you by the American Society for Clinical Pathology, 33 West Monroe Street, Suite 1600, Chicago, IL 60603.